Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...
MedPage Today on MSN
Bubbles of prostate cancer info; cancer drug tops moneymakers; small kidney tumors
News, features, and commentary about cancer-related issues ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
When it comes to detecting cancer, you want the fastest detection possible in order to treat it accurately and in a timely ...
Zacks Investment Research on MSN
JNJ gets EU nod for expanded use of Akeega in prostate cancer
J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory ...
Docetaxel added to androgen deprivation therapy (ADT) was the most cost-effective first-line regimen for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results